Supernus Pharmaceuticals, Inc. News Headlines

SUPN 
$8.05
*  
0.35
4.55%
Get SUPN Alerts
*Delayed - data as of Oct. 30, 2014  -  Find a broker to begin trading SUPN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Supernus' Trokendi XR Faces Generic Threat from Zydus - Analyst Blog
10/15/2014 6:45:00 PM - Zacks.com


Actavis in Acquisition Mode, Durata Deal to Boost Portfolio - Analyst Blog
10/7/2014 5:42:00 PM - Zacks.com


Supernus Up, Files Lawsuit against Actavis for Trokendi XR - Analyst Blog
10/6/2014 2:20:00 PM - Zacks.com


Dr. Reddy's (RDY) Generic Xopenex Launched in the US - Analyst Blog
9/25/2014 6:19:00 PM - Zacks.com


Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog
9/23/2014 4:55:00 PM - Zacks.com


Sector Update: Health Care Stocks Still Struggling; Supernus Pharmaceuticals Gains After Saying It Won't Need More Funding
9/23/2014 1:24:29 PM - MT Newswires


Sector Update: Health Care
9/23/2014 1:13:13 PM - MT Newswires


Others Overlooked Supernus Pharmaceuticals (SUPN), Should You Buy It Now? - Tale of the Tape
9/10/2014 8:47:00 AM - Zacks.com


Supernus' Trokendi XR Faces Generic Threat from Actavis - Analyst Blog
8/22/2014 4:55:00 PM - Zacks.com


Should You Get Rid of Corium International (CORI) Now? - Tale of the Tape
8/20/2014 8:55:00 AM - Zacks.com


Supernus's SPN-810 Gets Fast Track Status for ADHD - Analyst Blog
8/18/2014 1:30:00 PM - Zacks.com


Others Overlooked Supernus Pharmaceuticals (SUPN), Should You Buy It Now? - Tale of the Tape
8/18/2014 8:59:00 AM - Zacks.com


Supernus Finding Success, Looks Undervalued
8/15/2014 9:34:00 AM - Seeking Alpha


LGND Does A Deal, Q2 Revenue A Bitter Pill For BGMedicine, CRMD On Watch
8/14/2014 11:02:00 PM - RTT News


Sector Update: Health-Care Shares Higher Pre-Market
8/14/2014 8:45:13 AM - MT Newswires


Sector Update: Health Care
8/14/2014 8:42:43 AM - MT Newswires


FDA Grants Fast Track Designation For Supernus' SPN-810 - Quick Facts
8/14/2014 7:44:00 AM - RTT News


Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
7/10/2014 4:43:00 PM - Zacks.com


How Supernus Pharmaceuticals (SUPN) Stock Stands Out in a Strong Industry - Tale of the Tape
6/11/2014 8:52:00 AM - Zacks.com


Milestone Payment for Supernus - Analyst Blog
5/22/2014 11:30:00 AM - Zacks.com


Why I'm Long Supernus, A Small Specialty Pharma Company
5/20/2014 11:19:00 AM - Seeking Alpha


Commit To Buy Supernus Pharmaceuticals At $5, Earn 26% Using Options
4/7/2014 11:47:21 AM - BNK Invest


Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook
3/16/2014 5:16:00 PM - Seeking Alpha


Supernus' Oxtellar XR Gets 3rd U.S. Patent - Analyst Blog
1/8/2014 12:20:01 PM - Zacks.com


Zacks' Bear Of The Day: Magellan Health Services
12/30/2013 1:40:00 PM - Seeking Alpha